Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

7243 results

Sort By:

International REgistry of COnservative or Radical Treatment of Localized Kidney Tumors

Study ID: NCT05363657
Start Date: 2022-01-10
End Date: 2028-12-31
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

10000

Intervention / Treatment

Partial Nephrectomy (PN)

Radical Nephrectomy (RN)

Ablation therapy (AT)

Active Surveillance (AS)

Sponsor

Careggi Hospital-University

Source: clinicaltrials.gov

Share:
Add to list

CAR-T Cell Therapy, Mosunetuzumab and Polatuzumab for Treatment of Refractory/Relapsed Aggressive Non-Hodgkin's Lymphoma (NHL).

Study ID: NCT05260957
Start Date: 2022-12-14
End Date: 2027-12-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

22

Intervention / Treatment

Mosunetuzumab

Polatzumab

CAR-T Cell Therapy

Sponsor

Lazaros Lekakis

Source: clinicaltrials.gov

Share:
Add to list

Survivorship Care for Women Living With Ovarian Cancer: (POSTCARE-O)

Study ID: NCT05752448
Start Date: 2023-10-01
End Date: 2027-04-15
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

120

Intervention / Treatment

POSTCare Survivorship transition process

Sponsor

Baylor College of Medicine

Source: clinicaltrials.gov

Share:
Add to list

Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia

Study ID: NCT05753748
Start Date: 2023-01-24
End Date: 2029-04-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

680

Intervention / Treatment

Endoscopic Eradication Therapy

Sponsor

University of Colorado, Denver

Source: clinicaltrials.gov

Share:
Add to list

Assess Use of 18F-Fluciclovine for Patients With Large Brain Metastases Treated With Staged Stereotactic Radiosurgery

Study ID: NCT04689048
Start Date: 2022-04-04
End Date: 2026-12
Study Type

Interventional

Study Phase

Phase1

No. of Participants

20

Intervention / Treatment

18F fluciclovine

Sponsor

Baptist Health South Florida

Source: clinicaltrials.gov

Share:
Add to list

Tumor Treating Fields for the Treatment of Brainstem Gliomas

Study ID: NCT05310448
Start Date: 2022-05-11
End Date: 2026-05-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

10

Intervention / Treatment

Optune device

Sponsor

Emory University

Source: clinicaltrials.gov

Share:
Add to list

CARDINAL- A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TERN-701 in Participants With Chronic Myeloid Leukemia

Study ID: NCT06163430
Start Date: 2024-03-26
End Date: 2026-05-31
Study Type

Interventional

Study Phase

Phase1

No. of Participants

100

Intervention / Treatment

TERN-701

Sponsor

Terns, Inc.

Source: clinicaltrials.gov

Share:
Add to list

Sacituzumab Govitecan in Recurrent Glioblastoma

Study ID: NCT04559230
Start Date: 2022-01-06
End Date: 2026-08
Study Type

Interventional

Study Phase

Phase2

No. of Participants

32

Intervention / Treatment

Sacituzumab Govitan

Sponsor

The University of Texas Health Science Center at San Antonio

Source: clinicaltrials.gov

Share:
Add to list

Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors

Study ID: NCT05283330
Start Date: 2022-12-22
End Date: 2027-08
Study Type

Interventional

Study Phase

Phase1

No. of Participants

55

Intervention / Treatment

²¹²Pb-DOTAM-GRPR1

Sponsor

Orano Med LLC

Source: clinicaltrials.gov

Share:
Add to list

Using Ex Vivo Tumoroids To Predict Immunotherapy Response In NSCLC

Study ID: NCT05332925
Start Date: 2022-07-21
End Date: 2027-02
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

25

Intervention / Treatment

Standard of care immune checkpoint inhbitors

Sponsor

Jun Zhang, MD, PhD

Source: clinicaltrials.gov

Share:
Add to list